Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines. This evidence concerns the gene CYP1A1 and non-small cell lung carcinoma.